Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spannagl

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Platelets|June 24, 2006
Spreading of platelets: a morphological marker for platelet reactivity in peripheral arterial occlusive diseaseA J Reininger, C B Reininger, J Agneskirchner, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
AJNR. American Journal of Neuroradiology|January 29, 2008
Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stentingS Müller-Schunk, J Linn, N Peters, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Fibrinolysis caused by cardio-pulmonary bypass and shed mediastinal blood retransfusion--is it of clinical relevance?W Dietrich, A Barankay, P Wendt, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1994
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptorsM Siebeck, J C Cheronis, E Fink, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitusM Spannagl, C Drummer, H Fröschl, et al.
Thrombosis and Haemostasis|September 1, 1995
Effect of fibrinogen substitution in afibrinogenemia on hemorheology and platelet functionA J Reininger, C B Reininger, M Spannagl, et al.
Archives of Dermatology|June 1, 1993
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrateW Schramm, M Spannagl, K A Bauer, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1993
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operationsW Dietrich, H Mössinger, M Spannagl, et al.
Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Platelets|June 24, 2006
Spreading of platelets: a morphological marker for platelet reactivity in peripheral arterial occlusive diseaseA J Reininger, C B Reininger, J Agneskirchner, et al.
Klinische Wochenschrift|July 1, 1987
Increased thromboplastic potential in diabetes: a multifactorial phenomenonM M Landgraf-Leurs, T Ladik, B Smolka, et al.
AJNR. American Journal of Neuroradiology|January 29, 2008
Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stentingS Müller-Schunk, J Linn, N Peters, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Fibrinolysis caused by cardio-pulmonary bypass and shed mediastinal blood retransfusion--is it of clinical relevance?W Dietrich, A Barankay, P Wendt, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1994
Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptorsM Siebeck, J C Cheronis, E Fink, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitusM Spannagl, C Drummer, H Fröschl, et al.
Thrombosis and Haemostasis|September 1, 1995
Effect of fibrinogen substitution in afibrinogenemia on hemorheology and platelet functionA J Reininger, C B Reininger, M Spannagl, et al.
Archives of Dermatology|June 1, 1993
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrateW Schramm, M Spannagl, K A Bauer, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1993
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operationsW Dietrich, H Mössinger, M Spannagl, et al.
Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.
Pageof 13